Case-Control Study of Inflammatory Breast Cancer in North Africa
A Case-Control Study of Inflammatory Breast Cancer in North Africa
Sponsor: National Cancer Institute (NCI)
A observational or N/A phase clinical study on Diabetes, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 21 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 16 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Completed
-
Aug 2020 — Sep 2020 [monthly]
Completed
-
Jul 2020 — Aug 2020 [monthly]
Completed
-
May 2020 — Jul 2020 [monthly]
Completed
-
Mar 2020 — May 2020 [monthly]
Completed
-
Dec 2019 — Mar 2020 [monthly]
Completed
-
Nov 2019 — Dec 2019 [monthly]
Completed
-
Oct 2019 — Nov 2019 [monthly]
Completed
-
Jan 2019 — Oct 2019 [monthly]
Completed
-
Dec 2018 — Jan 2019 [monthly]
Completed
-
Sep 2018 — Dec 2018 [monthly]
Completed
-
Jun 2018 — Sep 2018 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Dec 2017 [monthly]
Recruiting NA
First recorded
Nov 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .